• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】26560

【品名】4-nitrophenethylamine

【CA登记号】24954-67-4

【 分 子 式 】C8H10N2O2

【 分 子 量 】166.17968

【元素组成】C 57.82% H 6.07% N 16.86% O 19.26%

与该中间体有关的原料药合成路线共 10 条

合成路线1

该中间体在本合成路线中的序号:(IV)

The reaction of 3-hydroxypyridine (I) with (S)-glycidol 3-nitrobenzenesulfonate (II) by means of sodium hexamethyldisylazide in DMSO gives 2(S)-(3-pyridyloxymethyl)oxirane (III), which is condensed with 2-(4-nitrophenyl)ethylamine (IV) by means of triethylamine in refluxing methanol yielding the chiral isopropanol (V). The protection of the secondary amino group of (V) with tert-butoxycarbonyl anhydride affords the carbamate (VI), which is submitted to reduction at the nitro group with H2 over palladium hydroxide in ethyl acetate providing the aniline derivative (VII). The acylation of (VII) with 4-iodobenzenesulfonyl chloride (VIII) and pyridine in dichloromethane affords the sulfonamide (IX), which is finally deprotected with 6N HCl in methanol.

1 Fisher, M.H.; Mathvink, R.J.; Ok, H.O.; Parmee, E.R.; Weber, A.E. (Merck & Co., Inc.); Substd. phenyl sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity. CA 2114712; EP 0611003; JP 1995010827; US 5451677; WO 9418161 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12911 3-Hydroxypyridine; 3-Pyridinol 109-00-2 C5H5NO 详情 详情
(II) 16259 (2S)oxiranylmethyl 3-nitrobenzenesulfonate; (S)-(+)-Glycidyl nosylate 115314-14-2 C9H9NO6S 详情 详情
(III) 27807 (2S)oxiranylmethyl 3-pyridinyl ether C8H9NO2 详情 详情
(IV) 26560 4-nitrophenethylamine 24954-67-4 C8H10N2O2 详情 详情
(V) 27808 (2S)-1-[(4-nitrophenethyl)amino]-3-(3-pyridinyloxy)-2-propanol C16H19N3O4 详情 详情
(VI) 27809 tert-butyl (2S)-2-hydroxy-3-(3-pyridinyloxy)propyl(4-nitrophenethyl)carbamate C21H27N3O6 详情 详情
(VII) 27810 tert-butyl 4-aminophenethyl[(2S)-2-hydroxy-3-(3-pyridinyloxy)propyl]carbamate C21H29N3O4 详情 详情
(VIII) 27811 4-iodobenzenesulfonyl chloride 98-61-3 C6H4ClIO2S 详情 详情
(IX) 27812 tert-butyl (2S)-2-hydroxy-3-(3-pyridinyloxy)propyl(4-[[(4-iodophenyl)sulfonyl]amino]phenethyl)carbamate C27H32IN3O6S 详情 详情

合成路线2

该中间体在本合成路线中的序号:(IV)

The reaction of 2-acetamido-5-hydroxypyridine (I) with (S)-glycidol 3-nitrobenzenesulfonate (II) by means of NaOH in DMF gives 2(S)-(6-acetamido-3-pyridyloxymethyl)oxirane (III), which is condensed with 2-(4-nitrophenyl)ethylamine (IV) by means of triethylamine in refluxing methanol yielding the chiral isopropanol (V). The protection of the secondary amino group of (V) with tert-butoxycarbonyl anhydride affords the carbamate (VI), which is submitted to reduction at the nitro group with H2 over Pd/C in ethyl acetate providing the aniline derivative (VII). The acylation of (VII) with 4-iodobenzenesulfonyl chloride (VIII) and pyridine in dichloromethane affords the sulfonamide (IX), which is finally deprotected with 2N HCl in refluxing methanol.

1 Fisher, M.H.; Mathvink, R.J.; Ok, H.O.; Parmee, E.R.; Weber, A.E. (Merck & Co., Inc.); Substd. phenyl sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity. CA 2114712; EP 0611003; JP 1995010827; US 5451677; WO 9418161 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 27813 N-(5-hydroxy-2-pyridinyl)acetamide C7H8N2O2 详情 详情
(II) 16259 (2S)oxiranylmethyl 3-nitrobenzenesulfonate; (S)-(+)-Glycidyl nosylate 115314-14-2 C9H9NO6S 详情 详情
(III) 27814 N-[5-[(2S)oxiranylmethoxy]-2-pyridinyl]acetamide C10H12N2O3 详情 详情
(IV) 26560 4-nitrophenethylamine 24954-67-4 C8H10N2O2 详情 详情
(V) 27815 N-[5-([(2S)-2-hydroxy-3-[(4-nitrophenethyl)amino]propyl]oxy)-2-pyridinyl]acetamide C18H22N4O5 详情 详情
(VI) 27816 tert-butyl (2S)-3-[[6-(acetamido)-3-pyridinyl]oxy]-2-hydroxypropyl(4-nitrophenethyl)carbamate C23H30N4O7 详情 详情
(VII) 27817 tert-butyl (2S)-3-[[6-(acetamido)-3-pyridinyl]oxy]-2-hydroxypropyl(4-aminophenethyl)carbamate C23H32N4O5 详情 详情
(VIII) 28870 4-isopropylbenzenesulfonyl chloride 54997-90-9 C9H11ClO2S 详情 详情
(IX) 27818 tert-butyl (2S)-3-[[6-(acetamido)-3-pyridinyl]oxy]-2-hydroxypropyl(4-[[(4-isopropylphenyl)sulfonyl]amino]phenethyl)carbamate C32H42N4O7S 详情 详情

合成路线3

该中间体在本合成路线中的序号:(XIX)

Alternatively, reaction of 6-chloronicotinic acid (XIII) with methyllithium-lithium bromide complex gave methyl ketone (XIV). This was brominated by means of dibromobarbituric acid (XV) to produce bromoketone (XVI). Asymmetric reduction of (XVI) with (-)-B-chlorodiisopinocampheylborane provided the (R)-bromohydrin (XVII), which was converted to epoxide (XVIII) with NaOH in aqueous THF. Epoxide (XVIII) opening with 4-nitrophenethylamine (XIX) produced amino alcohol (XX), which by further protection with Boc2O gave carbamate (XXI). Concomitant dechlorination and nitro group reduction in (XXI) by hydrogenation using Raney Nickel as catalyst provided amine (XI). This was finally converted to the target compound by means of sulfonylation and deprotection as above.

1 Naylor, E.M.; Colandrea, V.J.; Candelore, M.R.; Cascieri, M.A.; Colwell, L.F. Jr; Deng, L.; Feeney, W.P.; Forrest, M.J.; Hom, G.J.; MacIntyre, D.E.; Strader, C.D.; Tota, L.; Wang, P.R.; Wyvratt, M.J.; Fisher, M.H.; Weber, A.E.; 3-Pyridylethanolamines: Potent and selective human beta3 adrenergic receptor agonists. Bioorg Med Chem Lett 1998, 8, 21, 3087.
2 Fisher, M.H.; Naylor, E.M.; Ok, D.; Weber, A.E.; Shih, T.; Ok, H. (Merck & Co., Inc.); Substd. sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity. EP 0757674; JP 1997512275; US 5541197; US 5561142; WO 9529159 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IV) 26548 4-[[(hexylamino)carbonyl]amino]benzenesulfonyl chloride C13H19ClN2O3S 详情 详情
(XI) 26553 tert-butyl 4-aminophenethyl[(2R)-2-hydroxy-2-(3-pyridinyl)ethyl]carbamate C20H27N3O3 详情 详情
(XIII) 12996 6-Chloronicotinic acid 5326-23-8 C6H4ClNO2 详情 详情
(XIV) 26555 1-(6-chloro-3-pyridinyl)-1-ethanone C7H6ClNO 详情 详情
(XV) 26556 5,5-dibromo-2,4,6(1H,3H,5H)-pyrimidinetrione 511-67-1 C4H2Br2N2O3 详情 详情
(XVI) 26557 2-bromo-1-(6-chloro-3-pyridinyl)-1-ethanone C7H5BrClNO 详情 详情
(XVII) 26558 (1R)-2-bromo-1-(6-chloro-3-pyridinyl)-1-ethanol C7H7BrClNO 详情 详情
(XVIII) 26559 2-chloro-5-[(2R)oxiranyl]pyridine C7H6ClNO 详情 详情
(XIX) 26560 4-nitrophenethylamine 24954-67-4 C8H10N2O2 详情 详情
(XX) 26561 (1R)-1-(6-chloro-3-pyridinyl)-2-[(4-nitrophenethyl)amino]-1-ethanol C15H16ClN3O3 详情 详情
(XXI) 26562 tert-butyl (2R)-2-(6-chloro-3-pyridinyl)-2-hydroxyethyl(4-nitrophenethyl)carbamate C20H24ClN3O5 详情 详情

合成路线4

该中间体在本合成路线中的序号:(XII)

3-Acetylpyridine (I) was converted to the hydrochloride salt and then chlorinated with N-chlorosuccinimide to afford (chloroacetyl)pyridine (II). Asymmetric reduction of (II) by means of (-)-B-chlorodiisopinocampheylborane in THF produced the (R)-alcohol (III), which was cyclized to oxirane (IV) upon heating with K2CO3 in acetone. Epoxide (IV) opening with 4-aminophenethyl amine (V) in boiling MeOH gave aminoalcohol (VI). Then, selective protection of the aliphatic amine of (VI) as the tert-butyl carbamate yielded the target intermediate (VII). In a similar procedure, 2-chloro-5-acetylpyridine (VIII) was brominated employing dibromobarbituric acid in THF to afford bromide (IX), which was enantioselectively reduced to the (R)-alcohol (X). After cyclization of (X) to epoxide (XI), its opening with 4-nitrophenethyl amine (XII) yielded aminoalcohol (XIII). This was protected as the N-Boc derivative (XIV) and then, hydrogenation of the nitro group of (XIV) with concomitant halogen hydrogenolysis in the presence of Raney Nickel provided an alternative access to intermediate (VII).

1 Fisher, M.H.; Naylor, E.M.; Ok, D.; Weber, A.E.; Shih, T.; Ok, H. (Merck & Co., Inc.); Substd. sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity. EP 0757674; JP 1997512275; US 5541197; US 5561142; WO 9529159 .
2 Smith, R.G. (Merck & Co., Inc.); Combination therapy for the treatment of diabetes and obesity. JP 1999515027; WO 9716189 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12027 1-(3-Pyridinyl)-1-ethanone; 1-(3-Pyridinyl)ethanone 350-03-8 C7H7NO 详情 详情
(II) 26549 2-chloro-1-(3-pyridinyl)-1-ethanone C7H6ClNO 详情 详情
(III) 26550 (1R)-2-chloro-1-(3-pyridinyl)-1-ethanol C7H8ClNO 详情 详情
(IV) 26551 3-[(2R)oxiranyl]pyridine C7H7NO 详情 详情
(V) 18961 4-(2-aminoethyl)aniline; 4-(2-aminoethyl)phenylamine 13472-00-9 C8H12N2 详情 详情
(VI) 26552 (1R)-2-[(4-aminophenethyl)amino]-1-(3-pyridinyl)-1-ethanol C15H19N3O 详情 详情
(VII) 26553 tert-butyl 4-aminophenethyl[(2R)-2-hydroxy-2-(3-pyridinyl)ethyl]carbamate C20H27N3O3 详情 详情
(VIII) 26555 1-(6-chloro-3-pyridinyl)-1-ethanone C7H6ClNO 详情 详情
(IX) 26557 2-bromo-1-(6-chloro-3-pyridinyl)-1-ethanone C7H5BrClNO 详情 详情
(X) 26558 (1R)-2-bromo-1-(6-chloro-3-pyridinyl)-1-ethanol C7H7BrClNO 详情 详情
(XI) 26559 2-chloro-5-[(2R)oxiranyl]pyridine C7H6ClNO 详情 详情
(XII) 26560 4-nitrophenethylamine 24954-67-4 C8H10N2O2 详情 详情
(XIII) 26561 (1R)-1-(6-chloro-3-pyridinyl)-2-[(4-nitrophenethyl)amino]-1-ethanol C15H16ClN3O3 详情 详情
(XIV) 26562 tert-butyl (2R)-2-(6-chloro-3-pyridinyl)-2-hydroxyethyl(4-nitrophenethyl)carbamate C20H24ClN3O5 详情 详情

合成路线5

该中间体在本合成路线中的序号:(XII)

3-Acetylpyridine (I) was chlorinated employing N-chlorosuccinimide, and the resulting chloroketone (II) was enantioselectively reduced with (-)-B-chlorodiisopinocampheylborane (DIP-Cl) to furnish the chiral chlorohydrin (III). Intramolecular cyclization of (III) in the presence of K2CO3 in refluxing acetone produced (R)-(3-pyridyl)oxirane (IV). Further ring opening with 4-aminophenethylamine (V) gave rise to diaminoalcohol (VI), which was selectively proteced with Boc2O at the aliphatic amino group, yielding carbamate (VII). In a related alternative procedure, 2-chloro-5-acetylpyridine (VIII) was brominated to (IX) by means of dibromobarbituric acid (DBBA), followed by reduction of bromoketone (IX) with (-)-DIP-Cl. The resulting (R)-bromohydrin (X) was converted to epoxide (XI) by treatment with NaOH, and subsequent ring opening with 4-nitrophenethylamine (XII) provided aminoalcohol (XIII). Protection of the amino group of (XIII) with Boc2O afforded carbamate (XIV). Further reduction of the nitro group of (XIV) with simultaneous hydrogenolysis of the halogen atom furnished the target intermediate (VII).

1 Fisher, M.H.; Naylor, E.M.; Ok, D.; Weber, A.E.; Shih, T.; Ok, H. (Merck & Co., Inc.); Substd. sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity. EP 0757674; JP 1997512275; US 5541197; US 5561142; WO 9529159 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12027 1-(3-Pyridinyl)-1-ethanone; 1-(3-Pyridinyl)ethanone 350-03-8 C7H7NO 详情 详情
(II) 26549 2-chloro-1-(3-pyridinyl)-1-ethanone C7H6ClNO 详情 详情
(III) 26550 (1R)-2-chloro-1-(3-pyridinyl)-1-ethanol C7H8ClNO 详情 详情
(IV) 26551 3-[(2R)oxiranyl]pyridine C7H7NO 详情 详情
(V) 18961 4-(2-aminoethyl)aniline; 4-(2-aminoethyl)phenylamine 13472-00-9 C8H12N2 详情 详情
(VI) 26552 (1R)-2-[(4-aminophenethyl)amino]-1-(3-pyridinyl)-1-ethanol C15H19N3O 详情 详情
(VII) 26553 tert-butyl 4-aminophenethyl[(2R)-2-hydroxy-2-(3-pyridinyl)ethyl]carbamate C20H27N3O3 详情 详情
(VIII) 26555 1-(6-chloro-3-pyridinyl)-1-ethanone C7H6ClNO 详情 详情
(IX) 26557 2-bromo-1-(6-chloro-3-pyridinyl)-1-ethanone C7H5BrClNO 详情 详情
(X) 26558 (1R)-2-bromo-1-(6-chloro-3-pyridinyl)-1-ethanol C7H7BrClNO 详情 详情
(XI) 26559 2-chloro-5-[(2R)oxiranyl]pyridine C7H6ClNO 详情 详情
(XII) 26560 4-nitrophenethylamine 24954-67-4 C8H10N2O2 详情 详情
(XIII) 26561 (1R)-1-(6-chloro-3-pyridinyl)-2-[(4-nitrophenethyl)amino]-1-ethanol C15H16ClN3O3 详情 详情
(XIV) 26562 tert-butyl (2R)-2-(6-chloro-3-pyridinyl)-2-hydroxyethyl(4-nitrophenethyl)carbamate C20H24ClN3O5 详情 详情

合成路线6

该中间体在本合成路线中的序号:(I)

4-Nitrophenethylamine (I) was acylated with propionyl chloride and the resulting amide (II) was reduced to amine (III) with borane-dimethyl sulfide complex in refluxing THF. Amine (III) was then protected as the tert-butyl carbamate (IV) using Boc2O in THF. Subsequent catalytic hydrogenation of the nitro group of (IV) over Pd/C furnished aniline (V), which was coupled with 4-(trifluoromethoxy)benzenesulfonyl chloride (VI) to yield sulfonamide (VII). The Boc protecting group of (VII) was finally removed by treatment with trifluoroacetic acid.

1 Romero, A.G.; Leiby, J.A. (Pharmacia Corp.); Phenylsulfonamide-phenylethylamines useful as dopamine receptors. EP 1077935; WO 9958499 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 26560 4-nitrophenethylamine 24954-67-4 C8H10N2O2 详情 详情
(II) 47983 N-(4-nitrophenethyl)propanamide C11H14N2O3 详情 详情
(III) 47984 N-(4-nitrophenethyl)-1-propanamine; N-(4-nitrophenethyl)-N-propylamine C11H16N2O2 详情 详情
(IV) 47985 tert-butyl 4-nitrophenethyl(propyl)carbamate C16H24N2O4 详情 详情
(V) 47986 tert-butyl 4-aminophenethyl(propyl)carbamate C16H26N2O2 详情 详情
(VI) 47987 4-(trifluoromethoxy)benzenesulfonyl chloride 94108-56-2 C7H4ClF3O3S 详情 详情
(VII) 47988 tert-butyl propyl[4-([[4-(trifluoromethoxy)phenyl]sulfonyl]amino)phenethyl]carbamate C23H29F3N2O5S 详情 详情

合成路线7

该中间体在本合成路线中的序号:(VII)

Oxidation of aldehyde (I) with AgNO3 in EtOH/H2O in the presence of KOH provides carboxylic acid (II), which is then converted into acid chloride (III) by means of (COCl)2 in CH2Cl2 and catalytic DMF. Treatment of (III) with trimethylsilyl diazomethane (TMSCH2N2) in Et2O followed by HCl(g) in Et2O furnishes chloro derivative (IV), which is then enantioselectively reduced by means of (-)-Dip-Cl to afford alcohol (V). Treatment of (V) with NaOH in THF/H2O induces formation of epoxy derivative (VI), which is then condensed with amine (VII) to yield compound (VIII). N-Protection of (VIII) by reaction with Boc2O in CH2Cl2, followed by reduction of the nitro moiety by hydrogenation over Pd(OH)2 in MeOH, gives amine (IX). Amine (IX) is converted into sulfonamide (XI) by reaction with sulfonyl chloride (X) in CH2Cl2 in the presence of pyridine. Finally, the Boc group of (XI) is removed by means of TFA in CH2Cl2 to furnish the desired product.

1 Lambert, M.H.; Xu, H.E.; Collins, J.L.; Willson, T.M.; Henke, B.R.; Oplinger, J.A.; Brown, P.J.; PPAR agonists for metabolic diseases. 220th ACS Natl Meet (Aug 20 2000, Washington DC) 2000, Abst MEDI 197.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 44819 furo[2,3-b]pyridine-2-carbaldehyde C8H5NO2 详情 详情
(II) 44820 furo[2,3-b]pyridine-2-carboxylic acid C8H5NO3 详情 详情
(III) 44821 furo[2,3-b]pyridine-2-carbonyl chloride C8H4ClNO2 详情 详情
(IV) 44822 2-chloro-1-furo[2,3-b]pyridin-2-yl-1-ethanone C9H6ClNO2 详情 详情
(V) 44823 (1R)-2-chloro-1-furo[2,3-b]pyridin-2-yl-1-ethanol C9H8ClNO2 详情 详情
(VI) 44824 2-[(2S)oxiranyl]furo[2,3-b]pyridine C9H7NO2 详情 详情
(VII) 26560 4-nitrophenethylamine 24954-67-4 C8H10N2O2 详情 详情
(VIII) 44825 (1S)-1-furo[2,3-b]pyridin-2-yl-2-[(4-nitrophenethyl)amino]-1-ethanol C17H17N3O4 详情 详情
(IX) 44826 tert-butyl 4-aminophenethyl[(2S)-2-furo[2,3-b]pyridin-2-yl-2-hydroxyethyl]carbamate C22H27N3O4 详情 详情
(X) 44827 4-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzenesulfonyl chloride C16H9ClF3NO2S2 详情 详情
(XI) 44828 tert-butyl (2S)-2-furo[2,3-b]pyridin-2-yl-2-hydroxyethyl(4-[[(4-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]phenyl)sulfonyl]amino]phenethyl)carbamate C38H35F3N4O6S2 详情 详情

合成路线8

该中间体在本合成路线中的序号:(VII)

Reaction of 6-chloronicotinic acid (I) with methyllithium lithium bromide complex gives methyl ketone (II), which is treated with dibromobarbituric acid (III) in refluxing THF to afford bromoketone (IV). Asymmetric reduction of (IV) with (-)-DIP-chloride [(-)-B-chlorodiisopinocampheylborane] provides bromohydrin (V), which is converted into epoxide (VI) by treatment with NaOH in THF/H2O. Opening of the epoxide moiety of (VI) with p-nitrophenethylamine hydrochloride (VII) in MeOH in the presence of Et3N followed by N-protection with Boc2O in THF yields ethanolamine (VIII), which is then hydrogenated over Ni-Raney in EtOH/NaOH to furnish dechlorinated aniline (IX). Condensation of (IX) with 1,1-bis(methylsulfanyl)-2-nitroethylene (X) in isopropanol gives compound (XI), which is then subjected to reaction with aniline (XII) in isopropanol to afford nitroethylenediamine (XIII). Finally, the desired product is obtained by Boc removal of (XIII) by treatment with TFA in CH2Cl2.

1 Wyvratt, M.J.; Cascieri, M.A.; Liu, Y.; Parmee, E.R.; Tota, L.; Brockunier, L.L.; Candelore, M.R.; Fisher, M.H.; Weber, A.E.; Human beta3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamide moieties. Bioorg Med Chem Lett 2001, 11, 3, 379.
2 Naylor, E.M.; Colandrea, V.J.; Candelore, M.R.; Cascieri, M.A.; Colwell, L.F. Jr; Deng, L.; Feeney, W.P.; Forrest, M.J.; Hom, G.J.; MacIntyre, D.E.; Strader, C.D.; Tota, L.; Wang, P.R.; Wyvratt, M.J.; Fisher, M.H.; Weber, A.E.; 3-Pyridylethanolamines: Potent and selective human beta3 adrenergic receptor agonists. Bioorg Med Chem Lett 1998, 8, 21, 3087.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12996 6-Chloronicotinic acid 5326-23-8 C6H4ClNO2 详情 详情
(II) 26555 1-(6-chloro-3-pyridinyl)-1-ethanone C7H6ClNO 详情 详情
(III) 26556 5,5-dibromo-2,4,6(1H,3H,5H)-pyrimidinetrione 511-67-1 C4H2Br2N2O3 详情 详情
(IV) 26557 2-bromo-1-(6-chloro-3-pyridinyl)-1-ethanone C7H5BrClNO 详情 详情
(V) 26558 (1R)-2-bromo-1-(6-chloro-3-pyridinyl)-1-ethanol C7H7BrClNO 详情 详情
(VI) 26559 2-chloro-5-[(2R)oxiranyl]pyridine C7H6ClNO 详情 详情
(VII) 26560 4-nitrophenethylamine 24954-67-4 C8H10N2O2 详情 详情
(VIII) 26562 tert-butyl (2R)-2-(6-chloro-3-pyridinyl)-2-hydroxyethyl(4-nitrophenethyl)carbamate C20H24ClN3O5 详情 详情
(IX) 26553 tert-butyl 4-aminophenethyl[(2R)-2-hydroxy-2-(3-pyridinyl)ethyl]carbamate C20H27N3O3 详情 详情
(X) 13853 Methyl 1-(methylsulfanyl)-2-nitrovinyl sulfide; 1,1-Bis(methylthio)-2-nitroethylene; 1,1-Bis(methylsulfanyl)-2-nitroethylene 13623-94-4 C4H7NO2S2 详情 详情
(XI) 48294 tert-butyl (2R)-2-hydroxy-2-(3-pyridinyl)ethyl(4-[[(Z)-1-(methylsulfanyl)-2-nitroethenyl]amino]phenethyl)carbamate C23H30N4O5S 详情 详情
(XII) 48295 3-aminobenzamide 3544-24-9 C7H8N2O 详情 详情
(XIII) 48296 tert-butyl 4-([(Z)-1-[3-(aminocarbonyl)anilino]-2-nitroethenyl]amino)phenethyl[(2R)-2-hydroxy-2-(3-pyridinyl)ethyl]carbamate C29H34N6O6 详情 详情

合成路线9

该中间体在本合成路线中的序号:(III)

Alkylation of 1-napthol (I) with 1,2-dibromoethane provides the (naphthyloxy)ethyl bromide (II), which is condensed with p-nitrophenethylamine (III) to afford the secondary amine (IV). After acetylation of amine (IV) to produce acetamide (V), the nitro group of (V) is reduced by means of iron and HCl, yielding aniline (VI). Finally, acylation of the amino group of (VI) with methanesulfonyl chloride furnishes the target sulfonamide.

1 Liu, H.; et al.; New p-methylsufonamido phenylamine analogues as class III antiarrhythmic agents: Design, synthesis, biological assay, and 3D-QSAR analysis. J Med Chem 2002, 45, 14, 2953.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22935 alpha-naphthol; 1-naphthol 90-15-3 C10H8O 详情 详情
(II) 57707 2-bromoethyl 1-naphthyl ether; 1-(2-bromoethoxy)naphthalene C12H11BrO 详情 详情
(III) 26560 4-nitrophenethylamine 24954-67-4 C8H10N2O2 详情 详情
(IV) 57708 2-(1-naphthyloxy)-N-(4-nitrophenethyl)-1-ethanamine; N-[2-(1-naphthyloxy)ethyl]-N-(4-nitrophenethyl)amine C20H20N2O3 详情 详情
(V) 57709 N-[2-(1-naphthyloxy)ethyl]-N-(4-nitrophenethyl)acetamide C22H22N2O4 详情 详情
(VI) 57710 N-(4-aminophenethyl)-N-[2-(1-naphthyloxy)ethyl]acetamide C22H24N2O2 详情 详情

合成路线10

该中间体在本合成路线中的序号:(XVIII)

 

1 Cross PE, Arrowsmith JE, et aL 1990. Selective class Ⅲ antiarrhythmic agents.1.bis (arylalkyl) amines.J Med Chem, 332 1151~1155
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(III) 12397 N-Methyl-N-(4-nitrophenethyl)-2-(4-nitrophenoxy)-1-ethanamine; N-Methyl-N-(4-nitrophenethyl)-N-[2-(4-nitrophenoxy)ethyl]amine C17H19N3O5 详情 详情
(XVII) 63398 1-[(2-bromoethyl)oxy]-4-nitrobenzene; 2-bromoethyl 4-nitrophenyl ether 13288-06-7 C8H8BrNO3 详情 详情
(XVIII) 26560 4-nitrophenethylamine 24954-67-4 C8H10N2O2 详情 详情
(XIX) 66270 4-Nitro-N-[2-(4-nitrophenoxy)ethyl]benzeneethanamine 226992-13-8 C16H17N3O5 详情 详情
Extended Information